Cargando…
P34.05 Three Birds, One Stone: IVIG Use in Hypogammaglobulinemia, Checkpoint Inhibitor Pneumonitis, and Persistent COVID-19
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Published by Elsevier Inc.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8523128/ http://dx.doi.org/10.1016/j.jtho.2021.08.422 |
| _version_ | 1784585232247160832 |
|---|---|
| author | Olson, E. Crilley, T. Rawa, H. Gershner, K. Lycan, T. |
| author_facet | Olson, E. Crilley, T. Rawa, H. Gershner, K. Lycan, T. |
| author_sort | Olson, E. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8523128 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Published by Elsevier Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-85231282021-10-20 P34.05 Three Birds, One Stone: IVIG Use in Hypogammaglobulinemia, Checkpoint Inhibitor Pneumonitis, and Persistent COVID-19 Olson, E. Crilley, T. Rawa, H. Gershner, K. Lycan, T. J Thorac Oncol P34 Management of Lung Cancer in the Era of Covid-19 - Treatment of Lung Cancer during Covid-19 Published by Elsevier Inc. 2021-10 2021-10-18 /pmc/articles/PMC8523128/ http://dx.doi.org/10.1016/j.jtho.2021.08.422 Text en Copyright © 2021 Published by Elsevier Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | P34 Management of Lung Cancer in the Era of Covid-19 - Treatment of Lung Cancer during Covid-19 Olson, E. Crilley, T. Rawa, H. Gershner, K. Lycan, T. P34.05 Three Birds, One Stone: IVIG Use in Hypogammaglobulinemia, Checkpoint Inhibitor Pneumonitis, and Persistent COVID-19 |
| title | P34.05 Three Birds, One Stone: IVIG Use in Hypogammaglobulinemia, Checkpoint Inhibitor Pneumonitis, and Persistent COVID-19 |
| title_full | P34.05 Three Birds, One Stone: IVIG Use in Hypogammaglobulinemia, Checkpoint Inhibitor Pneumonitis, and Persistent COVID-19 |
| title_fullStr | P34.05 Three Birds, One Stone: IVIG Use in Hypogammaglobulinemia, Checkpoint Inhibitor Pneumonitis, and Persistent COVID-19 |
| title_full_unstemmed | P34.05 Three Birds, One Stone: IVIG Use in Hypogammaglobulinemia, Checkpoint Inhibitor Pneumonitis, and Persistent COVID-19 |
| title_short | P34.05 Three Birds, One Stone: IVIG Use in Hypogammaglobulinemia, Checkpoint Inhibitor Pneumonitis, and Persistent COVID-19 |
| title_sort | p34.05 three birds, one stone: ivig use in hypogammaglobulinemia, checkpoint inhibitor pneumonitis, and persistent covid-19 |
| topic | P34 Management of Lung Cancer in the Era of Covid-19 - Treatment of Lung Cancer during Covid-19 |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8523128/ http://dx.doi.org/10.1016/j.jtho.2021.08.422 |
| work_keys_str_mv | AT olsone p3405threebirdsonestoneiviguseinhypogammaglobulinemiacheckpointinhibitorpneumonitisandpersistentcovid19 AT crilleyt p3405threebirdsonestoneiviguseinhypogammaglobulinemiacheckpointinhibitorpneumonitisandpersistentcovid19 AT rawah p3405threebirdsonestoneiviguseinhypogammaglobulinemiacheckpointinhibitorpneumonitisandpersistentcovid19 AT gershnerk p3405threebirdsonestoneiviguseinhypogammaglobulinemiacheckpointinhibitorpneumonitisandpersistentcovid19 AT lycant p3405threebirdsonestoneiviguseinhypogammaglobulinemiacheckpointinhibitorpneumonitisandpersistentcovid19 |